DNOW Inc. is approaching its fourth-quarter earnings announcement, with financial experts closely watching its performance. This period's results will reveal how the company has navigated the recent market conditions, particularly given the varied outcomes from the previous quarter. The upcoming report will offer crucial insights into the company's financial health and future trajectory, as analysts have been actively revising their perspectives on its stock value.
Anticipated Q4 Performance and Analyst Forecasts
DNOW Inc. is preparing to disclose its financial results for the fourth quarter before the stock market opens on February 20. Market analysts have provided their outlook, forecasting the Houston, Texas-based enterprise to achieve quarterly earnings of 15 cents per share. This projection indicates a decrease from the 25 cents per share reported during the same period last year. Conversely, there is a strong consensus among analysts regarding the company's revenue, with expectations set at $969.5 million, a substantial rise from the $571 million recorded in the prior year, according to data from Benzinga Pro.
The company's previous financial disclosure on November 5 revealed a blend of positive and negative outcomes for its third quarter. As of Thursday's closing, DNOW's shares experienced a modest increase of 1.2%, reaching a price of $16.36. Investors and market watchers can review the most up-to-date analyst assessments and recommendations on the Benzinga Analyst Stock Ratings page, which allows for detailed sorting by various criteria including stock ticker, company name, analyst firm, and rating adjustments, providing a comprehensive overview of expert opinions on the company's stock.
Recent Analyst Ratings and Price Target Adjustments
In the lead-up to DNOW's upcoming earnings release, Wall Street's most reputable analysts have been actively adjusting their ratings and price targets for the company's stock. These evaluations reflect their updated perspectives on DNOW's financial prospects and market position. For instance, Stifel analyst Adam Farley reaffirmed a Buy rating for DNOW on November 24, 2025, setting a price target of $18. Farley has a notable accuracy rate of 62% in his predictions.
Meanwhile, Susquehanna analyst Charles Minervino upgraded DNOW's stock from a Neutral to a Positive rating on November 21, 2025, with a price target of $16. Minervino boasts an impressive accuracy rate of 77%. Earlier, on July 21, 2025, Stifel analyst Nathan Jones maintained a Buy rating but revised his price target downward from $19 to $18, reflecting a slight adjustment in his outlook. Jones has an accuracy rate of 82%. These recent changes highlight the dynamic nature of analyst expectations and provide valuable insights for those considering an investment in DNOW stock.